One Week of Low or Moderate Doses of Caffeinated Coffee Consumption Does Not Induce Tolerance to The Accute Effects of Caffeine on Sprint Performance
Year: 2021
Type: article
Study design: Clinical Trial
Abstract: Habituation to acute performance responses of caffeine intake is still an ongoing debate. The aim of this study was to evaluate the effects of acute and 1 week consumption of caffeinated coffee on intermittent sprint cycling performance (12x4s with 90s active recovery) (ISP). Twenty four male team-sport players randomly divided into 3 groups (8 athletes for each): 0.16 gr/kg decaffeinated coffee ingestion in a day for 1 week (PLAGROUP), 0.08 caffeinated + 0.08 decaffeinated coffee (providing 3 mg/kg caffeine) (0.16 gr/kg in total) (LOWGROUP) and 0.16 gr/kg caffeinated coffee (providing 6 mg/kg caffeine) (MODGROUP). Participants underwent three test session: At the first two test sessions, ISP test was performed with acute ingestion of decaffeinated coffee (PLA) or 6 mg/kg of caffeine provided by coffee (FIRSTCAF) to test acute effects of caffeine intake. At the third test session, following to 1 week of coffee consumption, to test if tolerance develops, ISP was performed with ingestion 6 mg/kg of caffeine provided by coffee (SECONDCAF). A 2-way repeated measures ANOVA showed that although average peak (p=0,39; η2 =0,13) and average mean (p=0,11; η2 =0,15) power of total 12 sprints during ISP test were not statistically different between 1 week consumption groups, FIRSTCAF and SECONDCAF significantly increased peak power (p=0,01; η2 =0,44) and mean power (p=0,01; η2 =0,46) in the first three sprints compared to PLA in all consumption groups. It appears that no tolerance was developed in 1 week consumption of 3 or 6 mg/kg/day of caffeine provided by coffee.
Authors: Raci Karayigit, Dicle Aras
Institution: Ankara University
Language: English
Topic: Coffee research and impacts
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3213247964